Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic review.

Frederick T GibsonKyle T Amber

Published in: International journal of dermatology (2019)

BAs may be suspected in patients developing AIBD while being treated for chronic inflammatory diseases. A majority of cases resolve upon cessation of the offending agent.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
oxidative stress
rheumatoid arthritis
ejection fraction
multiple sclerosis
prognostic factors
peritoneal dialysis
pulmonary embolism
patient reported outcomes
replacement therapy